In this issue and in a recent issue of Cell, Vahedi et al. and Samstein et al. provide new insights into the strategies used to establish an enhancer landscape during development of cell lineages. They report that enhancer landscapes characterizing T cell lineages are pre-established and strongly influenced by environmental stimuli.
Transcription in eukaryotes is regulated by sequence-specific DNA-binding proteins associated with a gene's promoter, which encompasses the transcription start site, and also by one or more distant control regions, including enhancers. Enhancers typically bind several DNAbinding proteins and coregulatory proteins that modulate chromatin structure and directly communicate with the transcription machinery positioned at the promoter. Until recently, our knowledge was based on studies of only a small number of model enhancers because enhancers were difficult to identify at a genome-wide scale. During the past few years, postgenomic technologies have revealed characteristic features of poised and active enhancers that have facilitated enhancer discovery. By taking advantage of this newfound capability, Vahedi et al. (2012) and Samstein et al. (2012) in this issue and in a recent issue of Cell have expanded our knowledge of the diverse strategies used to activate enhancers during the development of mammalian cell lineages. Vahedi et al. (2012) focused on active enhancers in two subtypes of mature helper T cells-Th1 and Th2 cells-which, in a simplistic view, promote immune responses to intracellular and extracellular microbial pathogens, respectively. These two cell types develop from the same naive Th cell precursor upon T cell receptor (TCR) engagement in the presence of different cytokine signals. Th1 development is catalyzed by IL-12 and IFN-g, which activate the STAT4 and STAT1 transcription factors, respectively. Among the many genes activated by these STAT proteins in the naive Th cell is Tbx21, which encodes the T-bet transcription factor that is considered to be a master regulator of Th1 development. In contrast, Th2 development is catalyzed by IL-4, which activates the STAT6 transcription factor that cooperates with the Th2-specifying factor, GATA3.
To identify enhancers that are active in mature Th1 and Th2 cells, Vahedi et al. (2012) performed chromatin immunoprecipitation sequencing (ChIP-seq) analysis for the transcriptional coactivator and histone acetyltransferase, p300. The significance of p300 association is thought to be distinct from that of another prominent enhancer mark, monomethylation of histone H3 at lysine 4 (H3K4me1). H3K4me1 is thought to mark both active enhancers and inactive enhancers that are poised for activation, whereas p300 is more closely associated with active enhancers (Heintzman et al., 2007; Visel et al., 2009; Ghisletti et al., 2010) .
The first surprise to emerge from this analysis was that a high percentage of p300-marked regions (excluding promoter regions) differed between the closely related Th1 and Th2 populations; 45% and 35% of p300 peaks were unique to Th1 or Th2 cells, respectively. Remarkably, extending the analysis to macrophages and embryonic stem cells revealed virtually no overlap in p300 peaks. One possible explanation for the vastly different p300 profiles is that p300 may not associate with the enhancers of broadly expressed genes, such as housekeeping genes. Consistent with this possibility, the authors were unable to find p300 peaks in the vicinity of a collection of broadly expressed genes. It remains to be determined whether the paucity of p300 peaks in the vicinity of these genes is because their enhancers generally function in a p300-independent manner, which is consistent with recent evidence of p300-independent enhancers (Krebs et al., 2011) , or because many broadly expressed genes may not be regulated by enhancers at all. As mentioned above, most early studies focused on enhancers for tissue-or developmentalstage-specific genes, raising the possibility that much of the current dogma about enhancer function does not extend to all genes. The second unexpected result emerged when Vahedi et al. (2012) examined the transcription factor requirements for p300 and H3K4me1 marking of the Th1-and Th2-specific enhancers. Previous studies had revealed that the marking of lineage-specific enhancers is dictated by key regulators of lineage specification (Ghisletti et al., 2010; Heinz et al., 2010; Mercer et al., 2011) . For example, PU.1, E2A, EBF, and other regulators of B cell development regulate the deposition of the H3K4me1 mark at many B-cell-specific enhancers, whereas PU.1 collaborates with C/EBP proteins at macrophage-specific enhancers (Heinz et al., 2010) . In addition to promoting deposition of H3K4me1, these factors promote nucleosome remodeling and confer susceptibility to activation by environmental stimuli. For example, microbial stimulation of mature macrophages results in the activation of NF-kB, which associates with a subset of the enhancers that had been marked by H3K4me1 at an early stage of macrophage development; NF-kB binding promotes enhancer activation, at least in part, through the recruitment of p300 (Ghisletti et al., 2010) . The preferential binding of environmentally induced factors to enhancers previously marked by lineage-specifying factors has also been observed in other cell types (Mullen et al., 2011; Trompouki et al., 2011) .
On the basis of these earlier studies, one might have expected that the Th1 specification factor, T-bet, would serve as a primary regulator of the enhancer landscape in Th1 cells by promoting H3K4me1 deposition and p300 recruitment. However, the p300-and H3K4me1-marked enhancer landscape was relatively unaltered when cells from T-bet-deficient (Tbx21 À/À ) mice were activated under Th1-promoting conditions. Instead, p300 recruitment to a large percentage of enhancers was dependent on the STAT4 and STAT1 proteins that respond to the cytokine microenvironment and mediate cytokine responses in a broad range of cell types. Importantly, H3K4me1 deposition at the Th1-specific enhancers appeared to precede the Th1-Th2 lineage decision. These results suggest that the STAT proteins promote the activation (as defined by p300 recruitment) of a subset of enhancers that had become poised for activation at an earlier stage of T cell development (Figure 1, left) . Interestingly, binding of STAT proteins led to loss of p300 engagement at another subset of enhancers, including enhancers associated with alternative cell lineages (Figure 1, right) , suggesting that STATs may exert both positive and negative effects on enhancer signatures depending on the chromatin context. The mechanism by which T-bet contributes to the Th1 cell fate decision is less certain, although the authors noted a stronger correlation between T-bet binding and transcriptional repression than transcriptional activation. Analogous to the Th1 results, p300 binding to Th2-specific enhancers was found to be more strongly dependent on the cytokine-induced factor STAT6 than on the lineage-specifying factor, GATA3.
Data presented in the recent study of Samstein et al. (2012) are consistent with the view that lineage-specifying transcription factors can function primarily by taking advantage of an enhancer landscape established by other transcription factors. This study focused on T regulatory (Treg) cells, which can either develop in the thymus from hematopoietic progenitors or in the periphery from naive T cells as an alternative to the Th1 and Th2 fates. Specification of the Treg lineage relies in the transcription factor FoxP3, which is both necessary and sufficient for Treg development. To determine how FoxP3 regulates Treg development, Samstein et al. (2012) compared the properties of promoters and enhancers in FoxP3+ Treg cells and in FoxP3À Treg progenitors. However, rather than examining p300 and H3K4me1, the authors performed genome-wide analyses of DNase I hypersensitivity. Genomic regions at which nucleosomes have been extensively remodeled or evicted become hypersensitive to DNase I digestion, and nucleosome remodeling/eviction generally correlates with enhancer and promoter activity. Samstein et al. (2012) found very few differences in the DNase hypersensitivity profile in FoxP3+ and FoxP3À cells. Furthermore, FoxP3 binding was observed primarily at regions that exhibited hypersensitivity prior to FoxP3 expression. Most of these sites exhibited hypersensitivity prior to TCR engagement, which is consistent with the view that much of the enhancer landscape was established at an early stage of T lineage development. However, a subset became hypersensitive following TCR engagement but before FoxP3 expression, implicating factors induced by TCR signaling, such as AP-1 and NFAT, in the nucleosome remodeling events that promote DNase hypersensitivity.
Strikingly, despite the use of different experimental methods, the two studies support a similar model in which transcription factors that have long been known to play critical roles in lineage specification, in particular T-bet and FoxP3, do not appear to play major roles in establishing the enhancer landscape that characterizes the lineages they regulate. Because the Th1, Th2, and Treg lineages involve the late differentiation of cells that already are fully committed to the T cell lineage, it is tempting to speculate that reliance on an enhancer landscape established at an earlier stage of development or in response to the environment will be unique to factors that act at late developmental stages. However, because early cell fate decisions can also be influenced by environmental stimuli and because tissue-specific enhancers can be marked in pluripotent embryonic stem cells, it remains possible that a subset of the factors that are critical for early cell fate decisions will also rely on a pre-established enhancer landscape.
One clear goal for the future will be to better understand the precise roles of factors like FoxP3 and T-bet in lineage specification. The current data suggest that FoxP3 may simply bind and activate a subset of enhancers within the available landscape, thereby promoting Treg development. In contrast, T-bet may act through different mechanisms, given the stronger association of T-bet binding with genes downregulated during Th1 development. Of broader relevance, improved tools for identifying functional enhancers and assigning them to their target genes and also for distinguishing functionally relevant transcription factor binding sites from those that may result from opportunistic interactions will be needed to more fully evaluate large genomic data sets. These technological advances would help reveal whether cell fate decisions are strongly dependent on the thousands of enhancers and binding sites for specification factors identified by using current technologies or whether the functional burden is carried by a relatively small subset of enhancers and interaction sites whose properties would then be of primary importance for future mechanistic studies.
